Context Therapeutics Inc.
CNTX
$0.7732
$0.00020.03%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 553.50% | 291.21% | 303.92% | -66.11% | -59.29% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 116.99% | -1.87% | -54.83% | -55.14% | -32.20% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 510.05% | 274.70% | 270.63% | -65.38% | -57.61% |
|
|||||
Total Current Assets | 510.05% | 274.70% | 270.63% | -65.38% | -57.61% |
Net Property, Plant & Equipment | 1,389.03% | 1,330.94% | -63.76% | -76.06% | -80.50% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 510.90% | 275.53% | 269.96% | -65.43% | -57.69% |
|
|||||
Total Accounts Payable | -39.06% | -43.72% | -48.65% | 69.00% | 154.51% |
Total Accrued Expenses | 29.32% | -59.19% | -61.28% | -71.79% | -15.59% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 485.88% | 56.99% | -51.97% | -69.00% | -89.82% |
Total Other Current Liabilities | 485.88% | 56.99% | -51.97% | -69.00% | -89.82% |
Total Current Liabilities | -34.43% | -49.35% | -57.30% | -19.33% | 30.68% |
|
|||||
Total Current Liabilities | -34.43% | -49.35% | -57.30% | -19.33% | 30.68% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -31.76% | -46.30% | -57.30% | -19.33% | 30.68% |
|
|||||
Common Stock & APIC | 137.78% | 120.03% | 120.47% | 1.31% | 1.37% |
Retained Earnings | -39.27% | -49.20% | -33.51% | -42.31% | -54.35% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 702.51% | 356.12% | 321.19% | -70.61% | -65.85% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 702.51% | 356.12% | 321.19% | -70.61% | -65.85% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 702.51% | 356.12% | 321.19% | -70.61% | -65.85% |
|